MedTrace Logo

Rapid Diagnostic Tests for Assessment of Initial Clearance and Detection of Recurrent Malaria Infections

NCT01843764 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2013-05-03

No results posted yet for this study

Summary

The aim of the study was to follow clearance of malaria infections and detection of new malaria episodes after initiation of antimalarial treatment in Tanzanian children. For this purpose the investigators used five diagnostic tools, 2 Rapid Diagnostic tests based on Histidine Rich Protein 2(HRP2) and Lactate dehydrogenase(LDH), 2 microscopical methods and one polymerase chain reaction (PCR). The investigators followed the 53 enrolled children during 42 days.

Conditions

  • Plasmodium Falciparum Malaria

Interventions

DEVICE

HRP2 and LDH based rapid diagnostic tests for P.falciparum

Sponsors & Collaborators

  • Muhimbili University of Health and Allied Sciences

    collaborator OTHER

  • Anders Björkman

    lead OTHER

Principal Investigators

  • Anders Björkman, Professor · Karolinska Institutet

Eligibility

Min Age
6 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-04-30
Completion
2012-06-30

Countries

  • Tanzania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01843764 on ClinicalTrials.gov